Navigation Links
Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy
Date:7/10/2012

SAN DIEGO, July 10, 2012 /PRNewswire/ -- Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors.  Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.

The researchers repeated these studies with in vivo models of blood cancers and demonstrated that the drug removed malignant cells from the bloodstream, while allowing normal healthy blood cells to grow, thus differentiating CX-5461 from genotoxic treatments. Targeting cancer's dependence upon Pol I to trigger cancer-specific activation of p53 signifies an entirely new approach to cancer therapy.

"The Pol I program represents the total package. Dr. Ross Hannan, Associate Professor and Group Leader at Peter Mac's Growth Regulation Laboratory, performed elegant studies to validate Pol I as a cancer target, Cylene created CX-5461 as the first selective small molecule inhibitor of Pol I, and together we showed that this approach potently kills malignant cells through activation of p53," stated William G. Rice, PhD, President and CEO of Cylene Pharmaceuticals. "Building on our mechanistic understanding of CX-5461, we have identified specific genetic markers to select patient populations with the most sensitive solid tumor or hematological cancers."

"The combination of cancer's reliance on Pol I, the impressive preclinical activity of CX-5461, the development of clear predictive and prognostic biomarkers and the novelty of the therapeutic strategy is compelling," continued Dr. Rice.  "As such, a First-in-Human clinical trial with CX-5461 is planned in collaboration with our colleagues at Peter M
'/>"/>

SOURCE Cylene Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
2. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
3. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
4. Global Kidney Cancer Drugs Industry
5. Trovagene to Study Trans-Renal KRAS Mutation Detection in Pancreatic Cancer
6. Prostate Cancer Center of New Jersey the Latest Center to Achieve High Honor of ACR-ASTRO Accreditation
7. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
8. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
9. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
10. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
11. Healthscope to commercially launch Circadians Cancers of Unknown Primary Diagnostic Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 Reportbuyer.com has added a new ... Technologies for Molecular Imaging Devices ... The objectives of this study are to ... used for diagnostic purposes, present global market measurements ... market segments as well as forecast market and ...
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com ... available in its catalogue: Asia-Pacific ... http://www.reportlinker.com/p02353210/Asia-Pacific-Infusion-Therapy-Device-Market.html Abstract: The ... therapy devices included volumetric infusion pumps, syringe infusion ... connectors and stopcocks. These categories are segmented based ...
(Date:9/2/2014)... 2, 2014 The Pharmaceutical Care Management Association ... (PBMs), today filed a lawsuit in Iowa ... Iowa law that restricts tools used ... state,s employers and consumers.  The law—HF ... restricting the use of Maximum Allowable Cost (MAC) lists ...
Breaking Medicine Technology:Global Markets and Technologies for Molecular Imaging Devices 2Global Markets and Technologies for Molecular Imaging Devices 3Global Markets and Technologies for Molecular Imaging Devices 4Global Markets and Technologies for Molecular Imaging Devices 5Global Markets and Technologies for Molecular Imaging Devices 6Global Markets and Technologies for Molecular Imaging Devices 7Global Markets and Technologies for Molecular Imaging Devices 8Global Markets and Technologies for Molecular Imaging Devices 9Global Markets and Technologies for Molecular Imaging Devices 10Global Markets and Technologies for Molecular Imaging Devices 11Global Markets and Technologies for Molecular Imaging Devices 12Global Markets and Technologies for Molecular Imaging Devices 13Global Markets and Technologies for Molecular Imaging Devices 14Global Markets and Technologies for Molecular Imaging Devices 15Global Markets and Technologies for Molecular Imaging Devices 16Global Markets and Technologies for Molecular Imaging Devices 17Global Markets and Technologies for Molecular Imaging Devices 18Global Markets and Technologies for Molecular Imaging Devices 19Global Markets and Technologies for Molecular Imaging Devices 20Global Markets and Technologies for Molecular Imaging Devices 21Global Markets and Technologies for Molecular Imaging Devices 22Global Markets and Technologies for Molecular Imaging Devices 23Global Markets and Technologies for Molecular Imaging Devices 24Global Markets and Technologies for Molecular Imaging Devices 25Asia-Pacific Infusion Therapy Device Market 2Asia-Pacific Infusion Therapy Device Market 3Asia-Pacific Infusion Therapy Device Market 4Asia-Pacific Infusion Therapy Device Market 5Asia-Pacific Infusion Therapy Device Market 6Asia-Pacific Infusion Therapy Device Market 7Asia-Pacific Infusion Therapy Device Market 8Asia-Pacific Infusion Therapy Device Market 9Asia-Pacific Infusion Therapy Device Market 10Asia-Pacific Infusion Therapy Device Market 11Asia-Pacific Infusion Therapy Device Market 12
... ZURICH, December 9, 2011 NHS National ... ALFApump System Sequana Medical announced today the ... System commissioned by the National Innovation Centre, the NHS ... up the development and use of innovations that will ...
... ATLANTA, Dec. 8, 2011 CardioMEMS announced today that ... Devices advisory panel voted against the Champion Heart Failure ... allows cardiologists to monitor heart failure patients from their ... is safe with a vote of 9-1, the majority ...
Cached Medicine Technology:NHS National Innovation Centre Estimates Sequana Medical's ALFApump® System Could Save the NHS £50 Million in ascites Care Annually 2FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure 2FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure 3
(Date:9/2/2014)... SC (PRWEB) September 02, 2014 The Wm. ... outreach fair and public town hall meeting for Veterans and ... available at the outreach fair to provide Veterans with valuable ... McMurry. “The town hall will provide a forum where we ... VA programs.” , The outreach fair will be held 4:45 ...
(Date:9/2/2014)... with lumpectomy followed by radiation therapy survived as ... to a large study conducted by researchers at ... Cancer Prevention Institute of California. , The comprehensive ... disease is the first to directly compare survival ... bilateral mastectomy (the removal of both breasts), unilateral ...
(Date:9/2/2014)... for their own spread throughout the body by coaxing ... according to a new report by Johns Hopkins scientists. ... Nature Communications , the researchers describe animal and cell-culture ... released by breast cancer cells. These molecules cause lymphatic ... to produce proteins called CCL5 and VEGF. CCL5 attracts ...
(Date:9/2/2014)... The Dream2Walk Foundation along with Gas Monkey Bar and ... Spinal Cord Injury Awareness Month featuring full band performances by ... Linear Automotive will be there hosting a Hot Rod, Rat ... 2pm. The car show is Pre 1964 only, with a ... concert. There will be trophies for top 3 and best ...
(Date:9/2/2014)... TUESDAY, Sept. 2, 2014 (HealthDay News) -- Two new ... One suggests that 6-year-olds who were breast-fed have a ... to bottle-fed infants, while the other finds a similar ... upholds the "many benefits of breast-feeding in the immediate ... Lenox Hill Hospital in New York City. She was ...
Breaking Medicine News(10 mins):Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 2Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 3Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 4Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Gas Monkey Hosts Concert in Dallas Benefiting Dream2Walk Foundation with Linear Automotive 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... HOUSTON - A genetic mutation that drives the initiation ... tumor growth and progression, scientists report in the journal ... the Kras oncogene opens up a new category of ... proved difficult to attack directly, said study co-lead author ...
... THURSDAY, April 26 (HealthDay News) -- Dogs who accidentally eat ... emit a toxic gas that can sicken veterinary staff, ... for Disease Control and Prevention say such canine gas attacks ... and such incidents "might be underreported." All of the ...
... issue of the journal Neurology , researchers at ... a simple, unobtrusive wrist sensor could gauge the severity ... but without the ungainly scalp electrodes and electrical ... clinically useful data from epilepsy patients as they go ...
... from University Hospitals (UH) Case Medical Center and Case ... findings that mammography remains beneficial for women in their ... issue of American Journal of Roentgenology , women ... mammography were diagnosed at earlier stages with smaller tumors ...
... , WEDNESDAY, April 25 (HealthDay News) -- When patients ... risk goes up quickly, new research finds. That ... warfarin or a newer, more expensive drug, Xarelto (rivaroxaban). ... which the upper chambers of the heart quiver or ...
... , WEDNESDAY, April 25 (HealthDay News) -- Heroin ... this sensitivity does not subside over the course of ... Researchers from the University of California-Los Angeles sought ... hyperalgesia) might change as a heroin addict moves from ...
Cached Medicine News:Health News:Mutant Kras drives pancreatic cancer maintenance via metabolic pathways 2Health News:Mutant Kras drives pancreatic cancer maintenance via metabolic pathways 3Health News:Mutant Kras drives pancreatic cancer maintenance via metabolic pathways 4Health News:Toxic Gas in Dogs' Vomit a Threat to Vets: CDC 2Health News:Gauging seizures' severity 2Health News:Gauging seizures' severity 3Health News:Study finds mammography beneficial for younger women 2Health News:Stopping Blood Thinners Raises Stroke Risk for Patients With Irregular Heartbeat 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: